By regulating the expression of troponin and shrinking the cytoskeleton to reverse epithelial-mesenchymal transition (EMT), baicalein can inhibit the growth of lung cancer cells through the targeted Src/Id1 pathway. This evidence concerns the gene ID1 and lung cancer.